Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Salman Khan Steps In To Help Longtime Body Double Parvez Kazi After Heart Surgery, Ensures Proper Medical Care

Salman Khan always wins hearts with his kindness. This time, the Bollywood superstar stepped in to support his longtime body double, Parvez Kazi, after he fell ill amid the ongoing shoot of Khan's upcoming film with Nayanthara and director Vamshi Paidipally. The health scare occurred on August 6, when Kazi began feeling unwell at home and subsequently underwent minor surgery. Salman Khan Takes…

Salman Khan Steps In To Help Longtime Body Double Parvez Kazi After Heart Surgery, Ensures Proper Medical Care

Bollywood star Salman Khan has shown his compassionate side by stepping in to assist his longtime body double, Parvez Kazi, following the latter's health scare during the filming of their upcoming film. Kazi fell ill on August 6 and underwent minor surgery, prompting Salman Khan to personally take charge of his medical care.

According to Kazi's manager, Piyush, Salman Khan personally ensured that Kazi received the necessary treatment and medical attention. The manager revealed that Salman Khan was "right there with us" and made sure Kazi got all the medical care he needed. Salman Khan even expressed that he treated Parvez like a younger brother, demonstrating his warm and supportive nature.

Since Kazi's recovery, the manager mentioned that the actor is now "absolutely fine" and has been advised to rest for a few days before returning to work. Kazi is expected to be back on set soon, continuing his collaboration with Salman Khan in their upcoming film alongside Nayanthara and director Vamshi Paidipally.

Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at freepressjournal.in →

More in Health & Medicine

Mahama opens 28th AMCOA Conference

President John Dramani Mahama on Monday opened the 28th Annual Conference of the Association of Medical Councils of Africa (AMCOA) in Accra with a call on African nations to take charge of and protect…

[Insight] Celltrion Expands Omlyclo 300mg Across Europe, Turning First-Mover Lead Into Tender Advantage

Celltrion is expanding the 300mg formulation of its omalizumab biosimilar Omlyclo across major European markets, a move that could help the South Korean biopharmaceutical company convert its…

  • Celltrion expands 300mg Omlyclo biosimilar to Germany, UK, France
  • European Commission approved 300mg formulation in November 2025
  • Strategy focuses on converting early lead into prescriptions and tender wins

More from Tuesday 25 August →